METHODS: Preterm infants born before 32 weeks of gestational age (GA) and weighing<
1500 g with no evidence of structural brain injury on conventional MRI and healthy pregnant …

Glucocorticoids (GC) are used in neonatal intensive care units to prevent or reduce the
severity of chronic lung disease in preterm infants and have been implicated in impaired …

Introduction: Bronchopulmonary dysplasia (BPD) is a common long-term adverse
complication of very premature delivery. Affected infants can suffer chronic respiratory …

OBJECTIVES: To compare neurocognitive, language, executive function, academic
achievement, neurologic and behavioral outcomes, and quality of life at age 10 years in …

Background and Objectives Early exposure to analgesics and sedatives is a key concern for
later learning disorders in children. The hippocampus, a key region for learning and …

Objectives To compare regional cerebral cortical microstructural organization between
preterm infants at term-equivalent age (TEA) and healthy full-term newborns, and to …

Context: Dexamethasone (DEX) is used to prevent virilization in female fetuses at risk of
congenital adrenal hyperplasia (CAH). Given that treatment has to be started before the …

There is substantial evidence that the use of glucocorticoids in neonates is associated with
an increased risk of neurodevelopmental disorders. However, it remains unclear how …

Background: Preterm infants are at risk for neurodevelopmental impairment. Intrauterine
growth restriction (IUGR) further increases this risk. Brain imaging studies are often utilized …

Aim Systemic postnatal corticosteroids are used to treat or prevent bronchopulmonary
dysplasia (BPD) in extremely preterm (EP) or extremely low birth weight (ELBW) infants but …